Radiation Oncology
Long-term results of RCT: Radiotherapy to the prostate for men with metastatic prostate cancer.
10 Jun, 2022 | 11:10h | UTC
ESTRO-ACROP guideline on surface guided radiation therapy.
7 Jun, 2022 | 10:53h | UTCESTRO-ACROP guideline on surface guided radiation therapy – Radiotherapy & Oncology
Commentary on Twitter
Now available! First European guideline on Surface Guided Radiation Therapy (SGRT): ESTRO-ACROP guideline on surface guided radiation therapy👉https://t.co/YC8Vk8g4h1 @OncologyAdvance @RadiotherapyOn1 #Radonc #Radiotherapy #Oncology
— ESTRO (@ESTRO_RT) June 2, 2022
ESTRO ACROP and SIOPE recommendations for myeloablative total body irradiation in children.
7 Jun, 2022 | 10:52h | UTC
M-A: Neoadjuvant short-course radiotherapy followed by consolidation chemotherapy before surgery for treating locally advanced rectal cancer.
3 Jun, 2022 | 10:46h | UTC
Phase 2 RCT: Efficacy of epigallocatechin-3-gallate in preventing dermatitis in patients with breast cancer receiving postoperative radiotherapy.
2 Jun, 2022 | 10:34h | UTCEfficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical Trial – JAMA Dermatology (free for a limited period)
Visual Abstract: Efficacy of Epigallocatechin-3-Gallate on Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy
M-A: Stereotactic radiosurgery vs. whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer.
30 May, 2022 | 10:41h | UTCStereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis – The Lancet Oncology (link to abstract – $ for full-text)
RCT: Effect of supine vs. prone breast radiotherapy on acute toxic effects of the skin among women with large breast size.
27 May, 2022 | 11:51h | UTCEffect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size: A Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Editorial: Prone Whole-Breast Radiotherapy—Better Than Supine? (free for a limited period)
Commentary on Twitter
Adjuvant breast radiotherapy in the prone position decreases acute skin toxicity in women with large breast size, as demonstrated by this multicenter randomized clinical trial. https://t.co/6Emr2Hy5KH #BCSM #RadOnc
— JAMA Oncology (@JAMAOnc) May 26, 2022
AUA/ASTRO Guideline: Clinically localized prostate cancer.
13 May, 2022 | 11:10h | UTCHomepage: Clinically Localized Prostate Cancer: AUA/ASTRO Guideline – American Urological Association
Part I: Introduction, Risk Assessment, Staging and Risk-Based Management
Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up
Part III: Principles of Radiation and Future Directions
Related:
Therapies for Clinically Localized Prostate Cancer – Agency for Healthcare Research and Quality
Radical prostatectomy versus deferred treatment for localised prostate cancer – Cochrane Library
ASTRO Guideline: Radiation therapy for brain metastases.
12 May, 2022 | 10:11h | UTCNews Release: ASTRO issues clinical guideline on radiation therapy for brain metastases – American Society for Radiation Oncology
Commentary on Twitter
ASTRO has released a guideline on #RadiationTherapy for brain metastases, which updates the original 2012 guideline. The publication in #PracticalRO includes treatment algorithms for limited & extensive brain metastases. Read here: https://t.co/5QRI0XqWHx #RadOnc pic.twitter.com/oNj2nzAKdm
— ASTRO (@ASTRO_org) May 10, 2022
Review: Advances in radiation oncology for the treatment of cervical cancer.
6 May, 2022 | 10:20h | UTCAdvances in Radiation Oncology for the Treatment of Cervical Cancer – Current Oncology
RCT: Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy.
1 May, 2022 | 23:20h | UTC
Consensus Statement: Management of patients with advanced prostate cancer.
25 Apr, 2022 | 00:50h | UTC
Commentary on Twitter
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021https://t.co/GjTGPx8IbN@APCCC_Lugano @Silke_Gillessen @AOmlin @AarmstrongDuke @piet_ost @Prof_IanD @DrSpratticus @charlesryanmd @Tilki_De @declangmurphy pic.twitter.com/FU0Fbjf8WZ
— European Urology (@EUplatinum) April 22, 2022
10-year results of a phase 3 RCT: High-dose radiotherapy and risk-adapted androgen deprivation in localized prostate cancer.
19 Apr, 2022 | 01:22h | UTCHigh-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial – The Lancet Oncology (link to abstract – $ for full-text)
Internal mammary node irradiation in patients with node-positive early breast cancer: fifteen-year results from the Danish breast cancer group internal mammary node study.
11 Apr, 2022 | 00:41h | UTCInternal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary from the author on Twitter (thread – click for more)
Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study https://t.co/fwtVF5Z6g7
— Lise Bech Jellesmark Thorsen (@Lise_BJT) April 9, 2022
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer.
25 Mar, 2022 | 08:21h | UTC
SEOM-TTCC clinical guideline in nasopharynx cancer.
25 Mar, 2022 | 08:20h | UTCSEOM-TTCC clinical guideline in nasopharynx cancer (2021) – Clinical and Translational Oncology
RCT: Short-term radiotherapy plus chemotherapy vs. long-term chemoradiotherapy in locally advanced rectal cancer.
18 Mar, 2022 | 07:39h | UTC
Cohort Study: adjuvant vs. early salvage radiation therapy after radical prostatectomy for pN1 prostate cancer.
17 Mar, 2022 | 08:09h | UTC
RCT: In patients with low-risk thyroid cancer, thyroidectomy without ablation radioiodine was noninferior to thyroidectomy with ablation radioiodine at 3 years.
10 Mar, 2022 | 10:59h | UTCThyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: New research casts doubt on a cornerstone of thyroid cancer treatment – STAT
Commentary on Twitter
In RCT involving patients with low-risk differentiated thyroid cancer undergoing thyroidectomy, a follow-up strategy that did not involve the use of radioiodine was noninferior to the use of radioiodine in the response to treatment at 3 years. https://t.co/RaJL3tdE4T pic.twitter.com/8nIPw50nkg
— NEJM (@NEJM) March 9, 2022
GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer.
10 Mar, 2022 | 10:35h | UTC
Review: Interaction between modern radiotherapy and immunotherapy for metastatic prostate cancer.
10 Mar, 2022 | 10:02h | UTC
RCT: Elective upper-neck vs. whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma.
9 Mar, 2022 | 08:17h | UTCElective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)
Commentaries:
Elective Upper-Neck vs Whole-Neck Irradiation in Nasopharyngeal Carcinoma – The ASCO Post
Lower Neck-Sparing RT Succeeds in Nasopharyngeal Carcinoma— Phase III trial also shows that upper-neck irradiation leads to fewer late toxicities – MedPage Today (link to abstract – $ for full-text)
Perspective | Ultrahypofractionated radiotherapy for localized prostate cancer: how far can we go?
28 Jan, 2022 | 08:09h | UTC
ASCO-SNO Guideline: Therapy for diffuse astrocytic and oligodendroglial tumors in adults.
26 Jan, 2022 | 01:19h | UTC
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.
21 Jan, 2022 | 09:36h | UTCTreatment for Brain Metastases: ASCO-SNO-ASTRO Guideline – Journal of Clinical Oncology